# Dopamine and Brain Computer Interface

> **NCT06729658** · EARLY_PHASE1 · COMPLETED · sponsor: **Max Planck Institute for Human Cognitive and Brain Sciences** · enrollment: 22 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Madopar
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06729658
- **Lead sponsor:** Max Planck Institute for Human Cognitive and Brain Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2023-02-27
- **Final completion:** 2024-08-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06729658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06729658, "Dopamine and Brain Computer Interface". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06729658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*